Prostate-specific antigen (PSA) is the main screening method to detect PC.1 Currently, the PSA cutoff value of 4 ng/mL has been used to perform prostate biopsy.2 The high serum PSA levels in patients with benign conditions may cause unnecessary biopsy procedures. This evidence concerns the gene KLK3 and pachyonychia congenita.